159 related articles for article (PubMed ID: 29117615)
1. Safety of Metformin Therapy in Patients with Type 2 Diabetes Living on an Oxygen-Deficient Plateau, Tibet, China.
Lv X; Ren Q; Zhou L; Geng Y; Song J; Mina A; Puchi B; Yang S; Meng S; Yang L
Exp Clin Endocrinol Diabetes; 2018 Jul; 126(7):460-464. PubMed ID: 29117615
[TBL] [Abstract][Full Text] [Related]
2. Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery.
Deden LN; Aarts EO; Aelfers SCW; van Borren MMGJ; Janssen IMC; Berends FJ; de Boer H
Obes Surg; 2018 Apr; 28(4):1080-1085. PubMed ID: 29058235
[TBL] [Abstract][Full Text] [Related]
3. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function.
Lim VC; Sum CF; Chan ES; Yeoh LY; Lee YM; Lim SC
Int J Clin Pract; 2007 Nov; 61(11):1829-33. PubMed ID: 17887995
[TBL] [Abstract][Full Text] [Related]
4. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
[TBL] [Abstract][Full Text] [Related]
5. Metformin in peritoneal dialysis: a pilot experience.
Al-Hwiesh AK; Abdul-Rahman IS; El-Deen MA; Larbi E; Divino-Filho JC; Al-Mohanna FA; Gupta KL
Perit Dial Int; 2014 Jun; 34(4):368-75. PubMed ID: 24584596
[TBL] [Abstract][Full Text] [Related]
6. Safety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus.
Hitchings AW; Archer JR; Srivastava SA; Baker EH
COPD; 2015 Apr; 12(2):126-31. PubMed ID: 25938184
[TBL] [Abstract][Full Text] [Related]
7. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.
Lalau JD; Race JM
Drug Saf; 1999 Apr; 20(4):377-84. PubMed ID: 10230584
[TBL] [Abstract][Full Text] [Related]
8. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
9. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
10. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series.
Yeh HC; Ting IW; Tsai CW; Wu JY; Kuo CC
BMC Nephrol; 2017 Jul; 18(1):229. PubMed ID: 28693440
[TBL] [Abstract][Full Text] [Related]
12. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
13. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
[TBL] [Abstract][Full Text] [Related]
14. Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation.
Lalau JD; Azzoug ML; Kajbaf F; Briet C; Desailloud R
Diabetes Metab; 2014 Jun; 40(3):220-3. PubMed ID: 24417956
[TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.
Boucaud-Maitre D; Ropers J; Porokhov B; Altman JJ; Bouhanick B; Doucet J; Girardin E; Kaloustian E; Lassmann Vague V; Emmerich J
Diabet Med; 2016 Nov; 33(11):1536-1543. PubMed ID: 26882092
[TBL] [Abstract][Full Text] [Related]
16. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
[TBL] [Abstract][Full Text] [Related]
17. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
[TBL] [Abstract][Full Text] [Related]
18. Metformin therapy in patients with chronic kidney disease.
Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
[TBL] [Abstract][Full Text] [Related]
19. The safety and pharmacokinetics of metformin in patients with chronic liver disease.
Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO
Aliment Pharmacol Ther; 2020 Mar; 51(5):565-575. PubMed ID: 31960986
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of metformin-associated lactate acidosis by haemodialysis].
Schousboe K; El Fassi D; Secher EL; Elming H; Rasmussen K; Hornum M
Ugeskr Laeger; 2012 Jun; 174(23):1604-6. PubMed ID: 22673381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
